In 2023, the market for hemodynamic monitoring systems is expected to reach US$669.05 million in 2017, increasing from US$917.28 million. During this period, it is projected to grow at a CAGR of 5.40%. Hemodynamic is a part of cardiovascular physiology which deals with blood circulation through the cardiovascular system. Hemodynamic monitoring systems help monitor adequate blood flow thus helping secure cardiovascular health, survival of patients post-surgery, longevity, and quality of life. Benefits of such a system include the elimination of repetitive data entry and data accessibility from different locations. Demand for such systems has risen significantly in recent years as various lifestyle-related factors have an increasing number of people suffering from hypertension and diabetes. Technological advancement and innovations in medical treatment have fuelled further growth. Geographically, North America is estimated to account for the largest market share over the projected period while the Asia Pacific is expected to witness’s highest growth.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the pressure sensors value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are GE Healthcare, Pulsion Medical Systems SE, Cheetah Medical, Inc., Philips Healthcare, and Edward Lifesciences among others.
The Hemodynamic Monitoring Systems market has been analyzed through following segments:
By End User
Hospitals and Clinics
Homecare and Ambulatory Sites
Middle East and Africa
Key insights offered
What will be the hemodynamic monitoring systems market size from 2017 to 2023?
How are the major drivers and restraints affecting the hemodynamic monitoring systems market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behavior
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.